FindTrial
Sign In

Acne(Pimple)and its treatment yavadilepa and guduchyadivati

An etiopathological study of Yauvanpidika (Acne) and its management with yavadilepa and guduchyadivati

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/06/008745
Enrollment
60
Registered
2017-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Yauvanpidika(Acne)

Interventions

Intervention1: Group A Yavadilepa and Guduchyadivati for Yauvanpidika: Yavadilepa is local application for Yauvanpidika applied with milk twice a day (morning and evening) Guduchyadivati is 500mg each

Sponsors

Institute of Post Graduate Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients having the signs and symptoms likes, Salmalikantak vata pidika on face / upper back and chest 2)Patients having signs and symptoms likes Ghana,Medogarbhtva,Ruja,Daha,Srava,Paka,Shoth, Vaivarnyata

Exclusion criteria

Exclusion criteria: 1)Pidika due any systemic disease like Prameha. 2)Patients having skin disease like Psoriasis, Atopic Dermatitis, Leprosy. 3)Chemically induced acne. 4)Patients with secondary infection and precautions puberty

Design outcomes

Primary

MeasureTime frame
efficacyTimepoint: 1 month—

Secondary

MeasureTime frame
safetyTimepoint: 1 month—

Countries

India

Contacts

Public ContactSoniya Parmar

IPGT RA GAU Jamnagar

drkspatel2007@yahoo.co.in9427574566

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026